By inhibiting aerobic glycolysis (e.g., by suppressing LDH/HIF-1α activity) and lipid anabolism (e.g., by reducing levels of hexadecanoic acid and FASN), curcumin markedly enhances the anti-tumor efficacy of sorafenib [57]. This evidence concerns the gene HIF1A and neoplasm.